Registration - In-house Corporation

Subject Matters

• Constitutional Issues
• Consumer Issues
• Employment and Training
• Financial Institutions
• Government Procurement
• Health
• Industry
• Intellectual Property
• Internal Trade
• International Relations
• International Trade
• Labour
• Regional Development
• Science and Technology
• Taxation and Finance

Subject Matter Details

Legislative Proposal, Bill or Resolution

• Food and Drugs Act and Bill C-51: An Act to amend the Food and Drugs Act and to make consequential amendments to other Acts. Specifically, with respect to the renewal of the drug approval process. Advocacy to ensure that Canada's review and approval process is timely, safe, effective, competitive and consistent with other jurisdictions.

Policies or Program

• Canada’s Access to Medicines Regime (CAMR), certified under the Patent Act, which allows developing countries to access drugs at a lower cost, with regard to ensuring that Intellectual Property rights and anti-diversion mechanisms continue to be respected.
• National Immunization Strategy. Advocacy to seek continued investment in vaccines funding and an overall strategy for prevention of disease in Canada.
• Patented Medicines Review Board (PMPRB), certified under the Patent Act and whose guidelines seek to ensure a balance between the prices set by manufacturers for patented medicines sold in Canada and the maintenance of an attractive environment for pharmaceutical research and development. Specifically with regard to ensuring that any actions and proposed changes by the PMPRB are consistent with the mandate assigned by Parliament.
• Science and Technology (S&T) Strategy: Mobilizing Science and Technology to Canada's Advantage. Advocacy for measures which will allow for commercialization in health care to occur and for Canada to remain competitive internationally on Intellectual Property and other fronts.
• The Common Drug Review (CDR) process for reviewing new drugs and providing listing recommendations to publicly funded drug benefit plans in Canada. Ensuring the access needs of Canadian patients are met by advocating on activities undertaken in the context of the CDR.
• The National Pharmaceutical Strategy (NPS) as agreed by First Ministers in 2004. Advocacy for ways to increase access to medicines and vaccines for Canadian patients.

Regulation

• Patented Medicines (Notice of Compliance) Regulations which seek to balance the protection of Intellectual Property (IP) and patents with cost containment. Advocacy to ensure that IP rights are respected and internationally competitive in order to promote Research and Development.

Communication Techniques

• Written communication
• Oral communication
• Grass-roots communication

Government Institutions

• Aboriginal Affairs and Northern Development Canada
• Atlantic Canada Opportunities Agency (ACOA)
• Canadian International Development Agency (CIDA)
• Canadian International Trade Tribunal (CITT)
• Competition Tribunal (CT)
• Environment Canada
• Federal Office of Regional Development – Quebec (FORD[Q])
• Finance Canada (FIN)
• Foreign Affairs and International Trade Canada (DFAITC)
• Health Canada (HC)
• Industry Canada
• Members of the House of Commons
• National Research Council (NRC)
• Natural Sciences and Engineering Research Council (NSERC)
• Patented Medicine Prices Review Board (PMPRB)
• Prime Minister's Office (PMO)
• Privy Council Office (PCO)
• Public Health Agency of Canada (PHAC)
• Public Works and Government Services Canada
• Revenue Canada (RC)
• Technology Partnerships Canada (TPC)
• Treasury Board Of Canada Secretariat (TBS)

Address:
7333 Mississauga Road
Mississauga, ON  L5N 6L4
Canada

Telephone number: 905-819-3000
Fax number: 905-819-3099  

Parent Company Information